Art. 9 Directive (EU) 2001/83

In forcesince 26 Jan 2007cited 6×

In addition to the requirements set out in Articles 8 and 10(1), an application for authorization to market a radionuclide generator shall also contain the following information and particulars:

a general description of the system together with a detailed description of the components of the system which may affect the composition or quality of the daughter nucleid preparation,

qualitative and quantitative particulars of the eluate or the sublimate.

  • Opinion of Mr Advocate General Bot delivered on 10 July 2008. The Queen, on the application of Synthon BV v Licensing Authority of the DeparDecision

    Articles 8 to 12 of Directive 2001/83 lay down the conditions for the grant of marketing authorisations.

    10 Jul 2008 · 62006CC0452

  • Judgment of the Court (Grand Chamber) of 23 January 2018. F. Hoffmann-La Roche Ltd and Others v Autorità Garante della Concorrenza e del MerDecision

    … som avses i artikel 8.3, artiklarna 10, 10a, 10b och 11 i direktiv 2001/83/EG eller i bilaga I till detta och i artikel 9.4 i denna förordning. Särskilt skall innehavaren skyndsamt underrätta [EMA], kommissionen och medlemsstaterna om …

    23 Jan 2018 · 62016CJ0179

  • Opinion of Mr Advocate General Jacobs delivered on 8 July 2004. The Queen, on the application of Approved Prescription Services Ltd v LicensDecision

    The Directive consolidates in one text a number of directives dealing with medicinal products and codifies amendments made to those directives. Chapter 1 of Title III of the Directive is made up of Articles 6 to 12, and deals with …

    8 Jul 2004 · 62003CC0036

  • Opinion of Advocate General Kokott delivered on 4 October 2018. Staat der Nederlanden v Warner-Lambert Company LLC.Decision

    Regulation No 1234/2008, which was adopted in particular on the basis of the original version of Article 35(1) of Directive 2001/83, [Only Article 23b of Directive 2001/83 now refers to the adoption of an implementing regulation.] …

    4 Oct 2018 · 62017CC0423

  • Opinion of Mr Advocate General Tizzano delivered on 11 September 2003. Kohlpharma GmbH v Bundesrepublik Deutschland.Decision

    Like Article 4 of Directive 65/65, Articles 8 to 11 of Directive 2001/83 set out the procedure, documents and particulars necessary for a marketing authorisation to be granted.

    11 Sep 2003 · 62002CC0112

  • Regeling proeven op farmaceutische productenLaw

    … Radiofarmaceutica Voor de toepassing van dit hoofdstuk wordt voor aanvragen op basis van artikel 6, lid 2, en artikel 9, van richtlijn 2001/83, een volledig dossier ingediend waarin de volgende specifieke bijzonderheden zijn …